Understanding abortion-related complications in health facilities: results from WHO multicountry survey on abortion (MCS-A) across 11 sub-Saharan African countries
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
BMJ
Abstract
Introduction Complications due to unsafe abortions are
an important cause of morbidity and mortality in many
sub-Saharan African countries. We aimed to characterise
abortion-related complication severity, describe their
management, and to report women’s experience of
abortion care in Africa.
Methods A cross-sectional study was implemented
in 210 health facilities across 11 sub-Saharan African
countries. Data were collected on women’s characteristics,
clinical information and women’s experience of abortion
care (using the audio computer-assisted self-interviewing
(ACASI) system). Severity of abortion complications
were organised in five hierarchical mutually exclusive
categories based on indicators present at assessment.
Descriptive bivariate analysis was performed for
women’s characteristics, management of complications
and reported experiences of abortion care by severity.
Generalised linear estimation models were used to assess
the association between women’s characteristics and
severity of complications.
Results There were 13 657 women who had an
abortion-related complication: 323 (2.4%) women were
classified with severe maternal outcomes, 957 (7.0%)
had potentially life-threatening complications, 7953
(58.2%) had moderate complications and 4424 (32.4%)
women had mild complications. Women who were single,
multiparous, presenting ≥13 weeks of gestational age and
where expulsion of products of conception occurred prior
to arrival to facility were more likely to experience severe
complications. For management, the commonly used
mechanical methods of uterine evacuation were manual
vacuum aspiration (76.9%), followed by dilation and
curettage (D&C) (20.1%). Most frequently used uterotonics
were oxytocin (50∙9%) and misoprostol (22.7%). Via ACASI,
602 (19.5%) women reported having an induced abortion.
Of those, misoprostol was the most commonly reported
method (54.3%).
Conclusion There is a critical need to increase access to
and quality of evidence-based safe abortion, postabortion
care and to improve understanding around women’s
experiences of abortion care.
Description
Research Article